Abstract

Patients with kidney failure represent a heterogeneous group, in which many factors, including age, the cause of kidney disease, comorbidities, and so forth, result in a wide variation of mortality risk.1 A number of predictive models are available to assess the patient’s individual risk of mortality at the time of dialysis initiation.2 However, few are applicable to patients treated with hemodialysis (HD) and peritoneal dialysis, many include nonroutinely available variables, and most importantly, few have been externally validated in independent cohorts, thus leaving their applicability and validity in clinical practice unanswered.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call